Protein-Modified PLGA Microspheres for Nerve Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for repairing peripheral nerve defects, such as autologous nerve transplantation, are limited by the scarcity of donor nerves and secondary damage, and tissue-engineered nerves face challenges with seed cell immunogenicity and growth factor stability.
Innovation Solution
Development of protein-modified PLGA microspheres, specifically laminin-modified PLGA microspheres loaded with a fat-soluble extract of Brucea javanica L., which are bound to silk fibroin fibers to create a tissue-engineered nerve conduit that promotes axon growth and myelination.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If autologous nerve transplantation is used to repair peripheral nerve defects, then the repair effect is satisfactory, but the source of donor nerves is inadequate and secondary damage is caused
Solution Approach 1:
The patent creates artificial nerve conduits that copy and mimic the structure and function of natural nerves. These conduits are engineered with extracellular matrix components and growth factors to replicate the natural nerve environment, providing a substitute that eliminates the need for donor nerve tissue while maintaining effective repair capabilities
Solution Approach 2:
The patent modifies the physical and chemical parameters of the nerve conduit materials to optimize their biological performance. By adjusting parameters such as porosity, degradation rate, and growth factor concentration, the conduits can effectively support nerve regeneration without requiring autologous donor tissue
2Reliability
If growth factors are added to scaffold material to construct tissue-engineered nerves, then nerve regeneration is promoted, but stability and efficiency must be maintained according to their physical and chemical properties
Solution Approach 1:
The patent embeds growth factors within the hierarchical structure of the extracellular matrix scaffold. Growth factors are nested within microparticles or vesicles that are themselves incorporated into the larger conduit structure, providing multiple levels of protection and controlled release mechanisms that maintain stability while promoting regeneration
Solution Approach 2:
The patent uses extracellular matrix components as intermediary carriers for growth factors. These matrix proteins serve as mediators that protect growth factors from degradation, control their release kinetics, and facilitate their interaction with regenerating nerve tissues, thereby maintaining both stability and efficiency
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The tissue-engineered nerve conduit effectively enhances myelination and nerve regeneration, providing a promising clinical solution for peripheral nerve injuries with improved biocompatibility and sustained release of active substances.
Implementation Method 1
PLGA is cross-linked with one or more of collagen, fibronectin, silk fibroin, and laminin through a cross-linking agent
Implementation Method 2
The crosslinking agent is a chemical crosslinking agent or a biological crosslinking agent, preferably a biological crosslinking agent, such as genipin, carbodiimide/N-hydroxysuccinimide (EDC/NHS), and sodium alginate
Implementation Method 3
The crosslinking agent is a chemical crosslinking agent or a biological crosslinking agent
Implementation Method 4
the fat-soluble extract of Brucea javanica L. Merr promotes the growth of peripheral DRG neurons and neurites
Implementation Method 5
the tissue-engineered nerve can effectively promote the myelination of the regenerated nerve after peripheral nerve injury
Data Source
AI summary
A protein-modified PLGA microsphere can be used to construct tissue-engineered nerve. The microspheres are loaded with active substances for treating peripheral nerve injury and are bound to tissue-engineered nerves. It has been shown that the prepared tissue-engineered nerve effectively promotes nerve regeneration after peripheral nerve injury.